Iulia Arif-Percă executive director of the Local American Working Group (LAWG), shares her insights on the launched initiatives to finding new funding alternatives that will increase Romanian patients’ access to innovative medicines. She highlights the constraining environment in which innovative companies operate in, and how LAWG’s work contributes to the progress. Furthermore, she reveals the association’s outlook for the future while identifying biotechnology as an opportunity for growth.
Companies choose to invest in an environment that can ensure stability and predictability and that provides fair public policy
